No insider purchases or sales are on record for BRAINSTORM CELL THERAPEUTICS INC. in the period covered. Source: SEC Form 4 filings, as of 2026-09-05.
Showing the most recent few. Create a free account to see 10 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
no 13F holders found for this ticker
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| OPERATING INCOME | $-10.0M | $-11.7M | $-21.4M | $-24.8M |
| NET INCOME | $-10.3M | $-11.6M | $-17.2M | $-24.3M |
| EPS (DILUTED) | -1.11 | -2.31 | -6.00 | -0.66 |
| OPERATING CASH FLOW | $-7.0M | $-9.1M | $-20.5M | $-19.3M |
| CASH | $29.0K | $187.0K | $1.3M | $772.0K |
No password to create and no card required. We store your email address and nothing else.